[ALNY] YoY Annual Result on 31-Dec-2016 [#FY]

Stock
[ALNY] Alnylam Pharmaceuticals, Inc.
Announcement Date
15-Feb-2017
Financial Year
2016
Quarter
31-Dec-2016 [#FY]
Profit Trend
YoY- -41.38%
Quarter Report
ALNY's Result
ALNY's Financial Summary
View:
Show?
Annual Result
31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 31/12/13 CAGR
Revenue 219,750 74,908 89,912 47,159 41,097 50,561 47,167 29.22%
PBT -885,253 -760,674 -490,874 -410,108 -290,073 -400,604 -91,920 45.83%
Tax 863 823 -25,603 -23,438 -24,909 -40,209 -2,695 -
NP -886,116 -761,497 -490,874 -410,108 -290,073 -360,395 -89,225 46.58%
Tax Rate - - - - - - - -
Total Cost 1,105,866 836,405 580,786 457,267 331,170 410,956 136,392 41.71%
Ratio Analysis
31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 31/12/13 CAGR
NP Margin -403.24 -1,016.58 -545.95 -869.63 -705.83 -712.79 -189.17 13.43%
Per Share
31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 31/12/13 CAGR
EPS -8.11 -7.57 -5.42 -4.79 -3.45 -4.85 -1.45 33.21%
EPS Diluted -8.11 -7.57 -5.42 -4.79 -3.45 -4.85 -1.45 33.21%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.